Clear Stroke Benefit Eludes Embolic Protection: PROTECTED TAVR

The trial failed to meet its primary endpoint, but benefits on disabling strokes muddy the waters for clinicians and patients regarding use of the Sentinel device.
Medscape Medical News

source https://www.medscape.com/viewarticle/980978?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?